NCT02697916 Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Status COMPLETED Phase NA
NCT02597127 Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) Status COMPLETED Phase PHASE2
NCT02576067 Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study Status COMPLETED Phase PHASE3
NCT02388971 Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease Status WITHDRAWN Phase PHASE2
NCT01666704 Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis Status WITHDRAWN Phase PHASE2
NCT01663402 ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab Status COMPLETED Phase PHASE3
NCT01572259 Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism Status UNKNOWN Phase PHASE3
NCT01433744 Short-term Changes on C-Reactive Protein (CRP) Levels After Non-surgical Periodontal Treatment Status COMPLETED Phase NA
NCT01353066 Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM) Status UNKNOWN Phase PHASE2/PHASE3
NCT01330602 Intima-Medial Thickness Guidance of Primary Prevention in Relatives of Patients With Early onSet Atherosclerosis Status UNKNOWN Phase NA
NCT01252953 REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00856817 Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation Status TERMINATED Phase PHASE4